Most cancers arise by an evolutionary process as mutations accumulate in chromosomes of somatic cells allowing them to escape the proliferative restrains that control cell growth. To counteract uncontrolled cellular proliferation, metazoans developed a number of innate tumor suppressing mechanisms, one of them being a terminal growth arrest called cellular senescence. In recent years, as we and others identified novel senescence markers, the biological role and importance of this stress response in arresting cells in pre- malignant lesions has been demonstrated. Why cells undergo senescence in vivo and thereby prevent tumor progression in humans however, remains poorly understood. Studies in human cell cultures revealed that cellular senescence is triggered by a number of stresses including dysfunction of telomeres, the physical ends of linear chromosomes. Our studies revealed that when telomeres become critically short, due to continuous cell proliferation and other stresses, they become recognized as double strand DNA breaks and initiate a signaling cascade that results in telomere dysfunction induced cellular senescence (TDIS). In this proposal we demonstrate that the majority of cells in three human cancer precursor lesions, but not in their malignant cancer counterparts, display dysfunctional telomeres and other markers of cellular senescence. Our data therefore indicate that TDIS is a critical and universal tumor suppressing mechanism that limits the growth of pre-malignant human neoplasias. In addition, we discovered that oncogenic signals, often associated with initiation of cancer growth, dramatically accelerate telomere erosion and dysfunction in pre-malignant human cells. It is therefore possible that telomeres act as sentinels of hyperproliferative stresses that rapidly induce cellular senescence once cellular growth control mechanisms become compromised. To test these predictions we will 1) analyze a number of common cancer precursor lesions as well as their malignant counterparts for markers of TDIS by fluorescence microscopy and 2) generate a mouse tumor model system that can analyze whether TDIS suppresses malignant progression of transformed human cells in tumor cell xenografts. In addition we will 3) determine the causes for telomere dysfunction under conditions that cause aberrant cell proliferation. We will use assays to measure telomere-shortening, -dysfunction and - structure, employ forward- and reverse- genetic interventions to manipulate telomere dysfunction, and identify telomere maintenance factors critical for triggering TDIS. The proposed experiments will reveal the impact of TDIS in preventing human tumor progression, identify novel diagnostic markers for tumor stage, and provide detailed insights into the causes of telomere dysfunction in pre-malignant human cells. This knowledge is critical for developing novel therapies that prevent the malignant progression of human cancer.

Public Health Relevance

The proposed studies will uncover the causes for growth arrest of early stage human tumors and will reveal telomere dysfunction as a novel and potentially ubiquitous biomarker for tumor stage. Not only is this knowledge critical for risk assessment and decisions on cancer treatment; but it will likely facilitate the development of novel anti-cancer drugs and therapies that stop progression of malignant- and metastatic- cancers.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Cancer Molecular Pathobiology Study Section (CAMP)
Program Officer
Sorg, Brian S
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Medicine & Dentistry of NJ
Schools of Medicine
United States
Zip Code
Boccardi, V; Cari, L; Nocentini, G et al. (2018) Telomeres Increasingly Develop Aberrant Structures in Aging Humans. J Gerontol A Biol Sci Med Sci :
Razdan, Neetu; Vasilopoulos, Themistoklis; Herbig, Utz (2018) Telomere dysfunction promotes transdifferentiation of human fibroblasts into myofibroblasts. Aging Cell 17:e12838
Seehawer, Marco; Heinzmann, Florian; D'Artista, Luana et al. (2018) Necroptosis microenvironment directs lineage commitment in liver cancer. Nature 562:69-75
Zhang, Gao; Wu, Lawrence W; Mender, Ilgen et al. (2018) Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma. Clin Cancer Res 24:4771-4784
Patel, Priyanka L; Herbig, Utz (2017) Detection of Dysfunctional Telomeres in Oncogene-Induced Senescence. Methods Mol Biol 1534:69-78
Hansen, Matthew E B; Hunt, Steven C; Stone, Rivka C et al. (2016) Shorter telomere length in Europeans than in Africans due to polygenetic adaptation. Hum Mol Genet 25:2324-2330
Patel, Priyanka L; Suram, Anitha; Mirani, Neena et al. (2016) Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence. Proc Natl Acad Sci U S A 113:E5024-33
Boccardi, Virginia; Razdan, Neetu; Kaplunov, Jessica et al. (2015) Stn1 is critical for telomere maintenance and long-term viability of somatic human cells. Aging Cell 14:372-81
Rossiello, Francesca; Herbig, Utz; Longhese, Maria Pia et al. (2014) Irreparable telomeric DNA damage and persistent DDR signalling as a shared causative mechanism of cellular senescence and ageing. Curr Opin Genet Dev 26:89-95
Suram, Anitha; Herbig, Utz (2014) The replicometer is broken: telomeres activate cellular senescence in response to genotoxic stresses. Aging Cell 13:780-6

Showing the most recent 10 out of 14 publications